EBMT 2018 | Endothelial dysfunction in transplant: defibrotide for VOD
Paul Richardson
Speaking at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, talks about the pooled analysis of the efficacy of defibrotide in adults with veno-occlusive disease (VOD).
Related videos
0:46 Nursing sessions: what to look for at EBMT 2020
John Murray
0:54 Pre- and post-CAR T-cell therapy costs
Carin Al Uyl-de Groot
4:24 CAR-T Meeting 2020: nurses' sessions highlights
John Murray
1:04 Expansion in CAR T-cell therapies and nurses’ education
John Murray
2:03 CAR T-cell therapy beyond cancer: fungal & viral infections
Michelle Seif
